B Group, Inc.
Source: SEC Form 13F · as of Mar 2026B Group, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $94.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$94.5M
| Company | Shares | Value |
|---|---|---|
| ADMAADMA BIOLOGICS, INC. | 3,207,542 | $28.9M |
| PRAXPraxis Precision Medicines, Inc. | 33,237 | $10.7M |
| ZLABZai Lab Ltd | 450,646 | $8.5M |
| TSHATaysha Gene Therapies, Inc. | 1,800,556 | $8.0M |
| GPCRStructure Therapeutics Inc. | 127,500 | $6.1M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 1,500,000 | $5.3M |
| SYRESpyre Therapeutics, Inc. | 100,000 | $5.0M |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 67,500 | $4.9M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 175,706 | $4.9M |
| AURAAura Biosciences, Inc. | 597,576 | $4.0M |
| ORKAOruka Therapeutics, Inc. | 75,000 | $3.7M |
| RAREUltragenyx Pharmaceutical Inc. | 135,000 | $2.8M |
| APGEApogee Therapeutics, Inc. | 7,500 | $631K |
| FHTXFoghorn Therapeutics Inc. | 102,000 | $488K |
| SLNOSOLENO THERAPEUTICS INC | 7,500 | $251K |
| REPLReplimune Group, Inc. | 26,000 | $199K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.